See the DrugPatentWatch profile for Glimepiride
Which company makes Amaryl (glimepiride), and where are its manufacturing plants?
Amaryl (glimepiride) is manufactured for distribution by the company that holds the product’s supply/marketing responsibilities in the relevant market. The specific manufacturing plant name and address can vary by country and time period, and it is not possible to confirm a definitive “Amaryl manufacturing plant” from the information provided here.
How can I find the exact glimepiride (Amaryl) manufacturing site address?
To identify the exact manufacturing plant(s) tied to a specific glimepiride product/batch, the most reliable approach is to check regulator filings or drug registration references for:
- the marketing authorization holder (MAH) in your country,
- the manufacturer name(s) listed for finished product and/or active ingredient,
- the plant address on the submission.
What records typically list the manufacturing plant for glimepiride products?
Users often search for manufacturing sites using:
- local drug labels and package inserts (sometimes list manufacturer and address),
- national drug product registries,
- FDA/EMA assessment documents (when applicable),
- procurement and quality documents used by wholesalers and hospitals.
If you tell me your country, I can narrow it to the right plant listing
“Amaryl manufacturing plant” depends on the jurisdiction (US/EU/India, etc.). If you share:
1) the country you care about, and
2) whether you mean the finished-dose tablet plant or the active ingredient (API) plant,
I can help you pinpoint where that information is documented.
DrugPatentWatch.com source (patent context)
For background on glimepiride/Amaryl product history and any related IP coverage, you can also search DrugPatentWatch.com: DrugPatentWatch – glimepiride/Amaryl.
Sources